Encompass Health Corp. (EHC) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1153674,
    "name": "Encompass Health Corp.",
    "stock_name": "Encompass Health Corp.",
    "full_name": "Encompass Health Corp.",
    "name_url": "stocks-analysis/encompass-health-corp",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "113.02",
    "chg": -0.02,
    "chgp": "-0.02%",
    "dir": -1,
    "prev_price": "113.04",
    "mcapval": "14,504.55",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 3365,
    "indexname": "S&P 500",
    "isin": "US29261A1007",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.44 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/encompass-health-corp-1153674-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Encompass Health Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-encompass-health-corp-technically-bullish-or-bearish-3673470",
        "imagepath": "",
        "date": "2025-11-05 11:17:32",
        "description": "As of 31 October 2025, the technical trend for Encompass Health Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by a daily moving average indicating mild bullishness, while the weekly MACD and KST are both mildly bearish. The monthly RSI shows bullishness, and Bollinger Bands are bullish on the monthly timeframe but mildly bearish on the weekly. \n\nIn terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -7.89% and -4.94% respectively, while it has outperformed the index year-to-date and over the longer term, with a YTD return of 26.84% compared to the S&P 500's 16.30%...."
      },
      {
        "title": "Is Encompass Health Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-encompass-health-corp-technically-bullish-or-bearish-3670672",
        "imagepath": "",
        "date": "2025-11-04 11:28:46",
        "description": "As of 31 October 2025, the technical trend for Encompass Health Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by a monthly bullish MACD and RSI, while the weekly indicators show mixed signals with a mildly bearish MACD and Bollinger Bands. The daily moving averages indicate a mildly bullish trend. \n\nIn terms of performance, Encompass Health has outperformed the S&P 500 year-to-date with a return of 25.68% compared to 16.30%, but has lagged over the past year with a return of 17.35% versus 19.89% for the index. Overall, the technical indicators suggest a cautious bullish outlook...."
      },
      {
        "title": "Is Encompass Health Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-encompass-health-corp-technically-bullish-or-bearish-3664364",
        "imagepath": "",
        "date": "2025-11-02 11:14:20",
        "description": "As of 31 October 2025, the technical trend for Encompass Health Corp. has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a mildly bearish stance, while the monthly indicators show bullish signals in MACD, RSI, and Dow Theory. The daily moving averages are mildly bullish, suggesting some short-term strength. \n\nIn terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -9.74% and -8.57% respectively, while it has outperformed the benchmark year-to-date (23.28% vs. 16.30%) and over the longer three and five-year periods. Overall, the current technical stance is mildly bullish, driven by mixed signals across different time frames...."
      },
      {
        "title": "Encompass Health Stock Hits Day Low of $107.52 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/encompass-health-stock-hits-day-low-of-10752-amid-price-pressure-3662069",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/EncompassHealth_priceRelatedfactors_3662069.png",
        "date": "2025-10-31 16:52:27",
        "description": "Encompass Health Corp. saw a notable decline in stock value, contrasting with the stable performance of the S&P 500. Despite recent short-term losses, the company has achieved a strong year-to-date performance and consistent returns over the past three years, supported by high management efficiency and robust cash flow."
      },
      {
        "title": "Encompass Health Opens Weak with 9.91% Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/encompass-health-opens-weak-with-991-gap-down-amid-market-concerns-3712413",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/EncompassHealth_gapdown_3712413.png",
        "date": "2025-10-31 16:36:26",
        "description": "Encompass Health Corp. experienced a notable decline in its stock performance, contrasting with the stable S&P 500. The company, with a market cap of approximately USD 14.5 billion, maintains a strong dividend yield and return on equity, reflecting solid profitability. Technical indicators suggest mixed trends in its performance."
      },
      {
        "title": "Encompass Health Corp. Hits New 52-Week High of $127.99",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/encompass-health-corp-hits-new-52-week-high-of-12799-3649189",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/EncompassHealth_priceRelatedfactors_3649189.png",
        "date": "2025-10-27 16:38:52",
        "description": "Encompass Health Corp. achieved a new 52-week high of USD 127.99 on October 24, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has a market capitalization of USD 14,505 million, a P/E ratio of 21.00, and a notable dividend yield of 23.73%."
      },
      {
        "title": "Is Encompass Health Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-encompass-health-corp-overvalued-or-undervalued-3637240",
        "imagepath": "",
        "date": "2025-10-21 11:58:21",
        "description": "As of 17 October 2025, the valuation grade for Encompass Health Corp. has moved from very expensive to attractive, indicating a shift towards a more favorable assessment. The company appears to be undervalued, supported by a P/E ratio of 21, a PEG ratio of 0.71, and an EV to EBITDA ratio of 13.02. In comparison to peers, Encompass Health's P/E ratio is lower than The Ensign Group, Inc. at 32.46, but higher than DaVita, Inc. at 9.71, suggesting a competitive position within its industry.\n\nThe company's recent performance has outpaced the S&P 500, with a year-to-date return of 34.87% compared to the index's 13.30%. This strong performance, coupled with a high dividend yield of 35.19% and robust ROE of 30.29%, reinforces the attractiveness of the stock at its current valuation...."
      },
      {
        "title": "Encompass Health Corp. Experiences Valuation Adjustment Amid Strong Market Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/encompass-health-corp-sees-valuation-grade-improve-from-very-expensive-to-attractive-3640639",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/EncompassHealth_valuationdot_3640639.png",
        "date": "2025-10-20 15:57:24",
        "description": "Encompass Health Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has adjusted its valuation metrics, including a P/E ratio of 21 and a price-to-book value of 6.49. The company has outperformed the S&P 500 in year-to-date and three-year returns, indicating strong operational efficiency and competitive positioning."
      },
      {
        "title": "Is Encompass Health Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-encompass-health-corp-overvalued-or-undervalued-3631644",
        "imagepath": "",
        "date": "2025-10-19 11:54:07",
        "description": "As of 17 October 2025, the valuation grade for Encompass Health Corp. has moved from very expensive to attractive, indicating a significant improvement in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 21, a PEG ratio of 0.71, and an EV to EBITDA ratio of 13.02. In comparison to peers, Encompass Health's P/E ratio is lower than The Ensign Group, Inc. at 32.46, but higher than DaVita, Inc. at 9.71, suggesting a competitive position within its industry.\n\nThe company's strong performance is further highlighted by a 34.87% year-to-date return compared to the S&P 500's 13.30%, and a remarkable 155.17% return over three years, significantly outpacing the benchmark's 81.19%. Overall, these metrics and comparisons reinforce the view that Encompass Health Corp. is currently undervalued in the market...."
      }
    ],
    "total": 19,
    "sid": "1153674",
    "stock_news_url": "https://www.marketsmojo.com/news/encompass-health-corp-1153674"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Encompass Health Corp. technically bullish or bearish?

2025-11-05 11:17:32

As of 31 October 2025, the technical trend for Encompass Health Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by a daily moving average indicating mild bullishness, while the weekly MACD and KST are both mildly bearish. The monthly RSI shows bullishness, and Bollinger Bands are bullish on the monthly timeframe but mildly bearish on the weekly. In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -7.89% and -4.94% respectively, while it has outperformed the index year-to-date and over the longer term, with a YTD return of 26.84% compared to the S&P 500's 16.30%....

Is Encompass Health Corp. technically bullish or bearish?

2025-11-04 11:28:46

As of 31 October 2025, the technical trend for Encompass Health Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by a monthly bullish MACD and RSI, while the weekly indicators show mixed signals with a mildly bearish MACD and Bollinger Bands. The daily moving averages indicate a mildly bullish trend. In terms of performance, Encompass Health has outperformed the S&P 500 year-to-date with a return of 25.68% compared to 16.30%, but has lagged over the past year with a return of 17.35% versus 19.89% for the index. Overall, the technical indicators suggest a cautious bullish outlook....

Is Encompass Health Corp. technically bullish or bearish?

2025-11-02 11:14:20

As of 31 October 2025, the technical trend for Encompass Health Corp. has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a mildly bearish stance, while the monthly indicators show bullish signals in MACD, RSI, and Dow Theory. The daily moving averages are mildly bullish, suggesting some short-term strength. In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -9.74% and -8.57% respectively, while it has outperformed the benchmark year-to-date (23.28% vs. 16.30%) and over the longer three and five-year periods. Overall, the current technical stance is mildly bullish, driven by mixed signals across different time frames....

Encompass Health Stock Hits Day Low of $107.52 Amid Price Pressure

2025-10-31 16:52:27

Encompass Health Corp. saw a notable decline in stock value, contrasting with the stable performance of the S&P 500. Despite recent short-term losses, the company has achieved a strong year-to-date performance and consistent returns over the past three years, supported by high management efficiency and robust cash flow.

Encompass Health Opens Weak with 9.91% Gap Down Amid Market Concerns

2025-10-31 16:36:26

Encompass Health Corp. experienced a notable decline in its stock performance, contrasting with the stable S&P 500. The company, with a market cap of approximately USD 14.5 billion, maintains a strong dividend yield and return on equity, reflecting solid profitability. Technical indicators suggest mixed trends in its performance.

Encompass Health Corp. Hits New 52-Week High of $127.99

2025-10-27 16:38:52

Encompass Health Corp. achieved a new 52-week high of USD 127.99 on October 24, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has a market capitalization of USD 14,505 million, a P/E ratio of 21.00, and a notable dividend yield of 23.73%.

Is Encompass Health Corp. overvalued or undervalued?

2025-10-21 11:58:21

As of 17 October 2025, the valuation grade for Encompass Health Corp. has moved from very expensive to attractive, indicating a shift towards a more favorable assessment. The company appears to be undervalued, supported by a P/E ratio of 21, a PEG ratio of 0.71, and an EV to EBITDA ratio of 13.02. In comparison to peers, Encompass Health's P/E ratio is lower than The Ensign Group, Inc. at 32.46, but higher than DaVita, Inc. at 9.71, suggesting a competitive position within its industry. The company's recent performance has outpaced the S&P 500, with a year-to-date return of 34.87% compared to the index's 13.30%. This strong performance, coupled with a high dividend yield of 35.19% and robust ROE of 30.29%, reinforces the attractiveness of the stock at its current valuation....

Encompass Health Corp. Experiences Valuation Adjustment Amid Strong Market Performance Indicators

2025-10-20 15:57:24

Encompass Health Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has adjusted its valuation metrics, including a P/E ratio of 21 and a price-to-book value of 6.49. The company has outperformed the S&P 500 in year-to-date and three-year returns, indicating strong operational efficiency and competitive positioning.

Is Encompass Health Corp. overvalued or undervalued?

2025-10-19 11:54:07

As of 17 October 2025, the valuation grade for Encompass Health Corp. has moved from very expensive to attractive, indicating a significant improvement in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 21, a PEG ratio of 0.71, and an EV to EBITDA ratio of 13.02. In comparison to peers, Encompass Health's P/E ratio is lower than The Ensign Group, Inc. at 32.46, but higher than DaVita, Inc. at 9.71, suggesting a competitive position within its industry. The company's strong performance is further highlighted by a 34.87% year-to-date return compared to the S&P 500's 13.30%, and a remarkable 155.17% return over three years, significantly outpacing the benchmark's 81.19%. Overall, these metrics and comparisons reinforce the view that Encompass Health Corp. is currently undervalued in the market....

View All News